8-K Announcements
6Material company update
Oct 29, 2026·SEC
Material company update
Apr 9, 2026·SEC
Material company update
Mar 3, 2026·SEC
Adtalem is successfully scaling its specialized healthcare education programs, evidenced by a 12.4% year-over-year revenue growth to $503.4 million in 2026Q2.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q1 2026Latest Jan 28, 2026 | $2.43+11.0% vs $2.19 | $503M+3.0% vs $489M |
Q4 2025 Oct 30, 2025 | $1.75+11.5% vs $1.57 | $462M+2.2% vs $452M |
Q3 2025 Aug 7, 2025 | $1.66+9.9% vs $1.51 | $457M+3.7% vs $441M |
Q2 2025 May 8, 2025 | $1.92+17.8% vs $1.63 | $466M+4.3% vs $447M |
Benchmark CVSA against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Covista Inc. (CVSA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $110.32 | $3.67B | 14.83 | 9.27% | 12.84% | 18.33% | — | |
| $26.88 | $1.69B | 9.36 | 24.2% | 21.06% | 17.93% | 2.07% | |
| $33.59 | $4.7B | 11.94 | 8.64% | 20.28% | 34.21% | 0.01% | |
| $1212.02 | $5.25B | 10.41 | 2.52% | 9.66% | 10.23% | 0.59% | |
| $52.20 | $1.19B | 114.75 | 3.96% | 0.74% | 0.6% | 4.83% | |
| $19.93 | $1.1B | 32.51 | 14.05% | 3.88% | 10.17% | — |
Covista Inc. (CVSA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Covista Inc. (CVSA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Apr 9, 2026·SEC
Mar 3, 2026·SEC
Get notified when CVSA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Covista Inc. (CVSA) stock FAQ — growth, dividends, profitability & financials explained
Covista Inc. (CVSA) reported $2.00B in revenue over the trailing twelve months. Revenue was $1.95B in fiscal year 2026. That is 536% more than the $307.3M of fiscal year 1997.
Covista Inc. (CVSA) grew revenue by 9.3% over the trailing twelve months, compared with the twelve months before.
Yes. Covista Inc. (CVSA) earned $257.2M in net income over the trailing twelve months (a 12.8% net margin).
Covista Inc. (CVSA) had a return on equity (ROE) of 18.3% over the trailing twelve months. That is above the market's typical 10-15%.
Covista Inc. (CVSA) generated $354.6M in free cash flow over the trailing twelve months.